Literature DB >> 6999031

Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates.

S J Mattingly, T W Milligan, A A Pierpont, D C Straus.   

Abstract

A total of 73 clinical isolates of group B streptococci obtained from diseased infants in 23 states and Puerto Rico were examined for extracellular neuraminidase production. The association of elevated levels of neuraminidase with serotype III isolates was evident in a broad geographical distribution.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6999031      PMCID： PMC273656          DOI： 10.1128/jcm.12.4.633-635.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

3.  The development of a phage-typing system for group-B streptococci.

Authors:  J Stringer
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

4.  Analysis of group B streptococcal types associated with disease in human infants and adults.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

5.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441
  5 in total
  3 in total

1.  Group B streptococcal neuraminidase is actually a hyaluronidase.

Authors:  D G Pritchard; B Lin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

2.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.

Authors:  D L Durham; S J Mattingly; T I Doran; T W Milligan; D C Straus
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.